In this study, we employed intestine‐specific NSD2 knockout or activation alongside combined analysis of CUT&Tag and transcriptome data to delineate the role and elucidate the mechanisms underlying intestinal NSD2 in NASH development. The gene discussed is NSD2; the disease is metabolic dysfunction-associated steatohepatitis.